Have a feature idea you'd love to see implemented?
Let us know!
ABOS Acumen Pharmaceuticals Inc
Price (delayed)
$2.74
Market cap
$164.62M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.12
Enterprise value
$126.15M
Highlights
The company's debt fell by 2.8% QoQ
The company's equity rose by 44% YoY but it fell by 7% QoQ
The company's quick ratio fell by 43% QoQ
Acumen Pharmaceuticals's net income has decreased by 40% YoY and by 16% from the previous quarter
Key stats
What are the main financial stats of ABOS
Market
Valuations
Earnings
Shares outstanding
60.08M
Market cap
$164.62M
Enterprise value
$126.15M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.67
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$62.28M
EBITDA
-$62.11M
Free cash flow
-$55.66M
Per share
Balance sheet
Liquidity
EPS
-$1.12
Free cash flow per share
-$0.93
Book value per share
$4.06
Revenue per share
$0
TBVPS
$4.81
Total assets
$288.91M
Total liabilities
$44.97M
Debt
$29.72M
Equity
$243.95M
Working capital
$251.55M
Debt to equity
0.12
Current ratio
17.37
Quick ratio
16.97
Net debt/EBITDA
0.62
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-21.9%
Return on equity
-24.6%
Return on invested capital
-26%
Return on capital employed
-22.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
ABOS stock price
How has the Acumen Pharmaceuticals stock price performed over time
Intraday
1.86%
1 week
3.01%
1 month
12.3%
1 year
-20.12%
YTD
-28.65%
QTD
10.48%
Financial performance
How have Acumen Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$76.68M
Net income
-$64.86M
Gross margin
N/A
Net margin
N/A
Acumen Pharmaceuticals's operating income has decreased by 47% YoY and by 17% QoQ
Acumen Pharmaceuticals's net income has decreased by 40% YoY and by 16% from the previous quarter
Growth
What is Acumen Pharmaceuticals's growth rate over time
Valuation
What is Acumen Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.67
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Acumen Pharmaceuticals's EPS has decreased by 6% from the previous quarter
The company's equity rose by 44% YoY but it fell by 7% QoQ
The P/B is 16% less than the last 4 quarters average of 0.8
Efficiency
How efficient is Acumen Pharmaceuticals business performance
ABOS's ROIC has soared by 59% YoY and by 2.6% from the previous quarter
ABOS's ROA is up by 10% year-on-year but it is down by 5% since the previous quarter
ABOS's return on equity is down by 7% since the previous quarter but it is up by 3.1% year-on-year
Dividends
What is ABOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for ABOS.
Financial health
How did Acumen Pharmaceuticals financials performed over time
Acumen Pharmaceuticals's total assets has soared by 63% YoY but it has decreased by 4% from the previous quarter
The company's quick ratio fell by 43% QoQ
The company's debt is 88% lower than its equity
The company's equity rose by 44% YoY but it fell by 7% QoQ
The company's debt fell by 2.8% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.